Jade Biosciences JBIO
NASDAQ JBIO
$15.10 +0.24 (+1.62%)
As of: Oct 21, 2026 · 3:59 PM EDT

Jade Biosciences (JBIO) Total Liabilities (2020 - 2026)

Updated

Jade Biosciences' Total Liabilities came in at $32.2 million for Q2 2026, up 43.7% from $22.41 million a year earlier and up 40.2% from the prior quarter.

Analysis

Jade Biosciences (JBIO) Total Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Jade Biosciences' Total Liabilities was $17.26 million, down 85.6% from FY2024.

  • Total Liabilities carries a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
  • Going back by year, Total Liabilities was $119.6 million in FY2024 (+565.8%), $17.96 million in FY2023 (+109.9%), $8.56 million in FY2022 (+190.6%) and $2.95 million in FY2021 (-83.7%).
  • The Q2 2026 figure represents the highest quarterly Total Liabilities since Q1 2025.
  • Year-over-year, Total Liabilities increased in four of the last eight quarters, with growth averaging 225.4%.
  • The fastest year-over-year change in Total Liabilities over five years came in Q1 2025 (growth of 911.8%), and the weakest in Q2 2022 (a decline of 94.5%).
  • Business Quant data shows JBIO's Total Liabilities at $22.97 million (Q1 2026), $17.26 million (Q4 2025) and $23.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 116.09 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 141.05 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 37.53 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 115.64 Bn
10 Jade Biosciences 925.91 Mn -381.71 Mn - 32.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.20 Mn
Mar 31, 2026 22.97 Mn
Dec 31, 2025 17.26 Mn
Sep 30, 2025 23.10 Mn
Jun 30, 2025 22.41 Mn
Mar 31, 2025 161.04 Mn
Dec 31, 2024 119.60 Mn
Sep 30, 2024 107.82 Mn
Jun 30, 2024 112.28 Mn
Mar 31, 2024 15.92 Mn
Dec 31, 2023 17.96 Mn
Sep 30, 2023 15.15 Mn
Jun 30, 2023 13.83 Mn
Mar 31, 2023 11.30 Mn
Dec 31, 2022 8.56 Mn
Sep 30, 2022 8.52 Mn
Jun 30, 2022 4.63 Mn
Mar 31, 2022 5.05 Mn
Dec 31, 2021 2.95 Mn
Sep 30, 2021 4.28 Mn
API Access

Jade Biosciences Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=JBIO&period=max&api_key=YOUR_API_KEY